Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

AMERICAN HEALTHCARE REIT ($AHR) Releases Q2 2026 Earnings

None

AMERICAN HEALTHCARE REIT ($AHR) posted quarterly earnings results for Q2 2026 on Thursday, August 6th. The company reported earnings of $0.54 per share, beating estimates of $0.17 by $0.37. The company also reported revenue of $670,960,000, beating estimates of $669,795,811 by $1,164,189.

You can see Quiver Quantitative's $AHR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive AHR Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

AMERICAN HEALTHCARE REIT Insider Trading Activity

AHR Insider Trades

AMERICAN HEALTHCARE REIT insiders have traded $AHR stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $AHR stock by insiders over the last 6 months:

  • BRIAN PEAY (Chief Financial Officer) sold 25,000 shares for an estimated $1,267,402
  • MARK E. FOSTER (EVP, GC & Secretary) has made 0 purchases and 3 sales selling 6,500 shares for an estimated $315,190.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

AMERICAN HEALTHCARE REIT Hedge Fund Activity

We have seen 264 institutional investors add shares of AMERICAN HEALTHCARE REIT stock to their portfolio, and 232 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

AMERICAN HEALTHCARE REIT Price Targets

Multiple analysts have issued price targets for $AHR recently. We have seen 7 analysts offer price targets for $AHR in the last 6 months, with a median target of $57.0.

Here are some recent targets:

  • Michael Goldsmith from UBS set a target price of $63.0 on 07/08/2026
  • Richard Hightower from Barclays set a target price of $61.0 on 07/07/2026
  • Nick Joseph from Citigroup set a target price of $55.0 on 06/23/2026
  • Nicholas Yulico from Scotiabank set a target price of $51.0 on 06/18/2026
  • Austin Wurschmidt from Keybanc set a target price of $58.0 on 05/28/2026
  • Michael Carroll from RBC Capital set a target price of $56.0 on 05/26/2026
  • Michael Lewis from Truist Securities set a target price of $57.0 on 03/13/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles